Vivanza (vardenafil)
- Region
- 🇪🇺 EU
- Active substance
- vardenafil
- Company
- Bayer AG
- Status
- Withdrawn
- Therapeutic area
- Erectile Dysfunction
- EU approval
- Tue 04 Mar 2003
- Application
- EMEA/H/C/000488
- ATC
- G04BE09
- Official record
- www.ema.europa.eu
Indication
Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Vivanza to be effective, sexual stimulation is required. Vivanza is not indicated for use by women.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Levitra Authorised · Bayer AG
Follow Vivanza
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.